Back

Influenza-specific effector memory B cells predict long-lived antibody responses to vaccination in humans

Nellore, A.; Zumaquero, E.; Scharer, C. D.; King, R. G.; Tipton, C. M.; Fucile, C.; Mousseau, B.; Bradley, J. E.; Mi, T.; Goepfert, P. A.; Kearney, J. F.; Boss, J. M.; Randall, T. D.; Sanz, I.; Rosenberg, A.; Lund, F. E.

2021-02-18 immunology
10.1101/643973 bioRxiv
Show abstract

Seasonal influenza vaccination elicits hemagglutinin (HA)-specific CD27+ memory B cells (Bmem) that differ in expression of T-bet, BACH2 and TCF7. T-bethiBACH2loTCF7lo Bmem are transcriptionally similar to effector-like memory cells while T-betloBACH2+TCF7+ Bmem exhibit stem-like central memory properties. T-bethi Bmem do not express plasma cell-specific transcription factors but do exhibit transcriptional, epigenetic, metabolic and functional changes that poise the cells for antibody production. Consistent with these changes, D7 HA+ T-bethi Bmem express intracellular immunoglobulin and T-bethi Bmem differentiate more rapidly into ASCs in vitro. The T-bethi Bmem response positively correlates with long-lived humoral immunity and clonotypes from T-bethi Bmem are represented in the early secondary ASC response to repeat vaccination, suggesting that this effector-like population can be used to predict vaccine durability and recall potential.

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.